COR Q1 2021 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q1 2021 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$52.5B+9.7% YoY

Gross Profit

$1.4B2.6% margin

Operating Income

$618M1.2% margin

Net Income

$375M0.7% margin

EPS (Diluted)

$1.81

QoQ Revenue Growth

+6.6%

Cash Flow

Operating Cash Flow

$903M

Free Cash Flow

$838M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$45.8B

Total Liabilities

$46.4B

Stockholders' Equity

-$697M

Cash & Equivalents

$4.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52.5B	$47.9B	+9.7%
Gross Profit	$1.4B	$1.1B	+21.0%
Operating Income	$618M	$432M	+42.9%
Net Income	$375M	$188M	+99.8%

Revenue Segments

Pharmaceutical Distribution

$50.5B96%

Other Segments

$2.1B4%

Geographic Segments

Other Segments

$2.1B100%